WCC 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence.
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2016
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 31 Jan 2013 Planned end date changed from 1 Sep 2018 to 1 Sep 2017 as reported by ClinicalTrials.gov.